Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - ramipril - tablet - 10 milligram(s) - ace inhibitors, plain; ramipril

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - ramipril - tablet - 5 milligram(s) - ace inhibitors, plain; ramipril

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - ramipril - tablet - 2.5 milligram(s) - ace inhibitors, plain; ramipril

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - lisinopril dihydrate - tablet - 10 milligram(s) - ace inhibitors, plain; lisinopril

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - lisinopril dihydrate - tablet - 2.5 milligram(s) - ace inhibitors, plain; lisinopril

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - lisinopril dihydrate - tablet - 20 milligram(s) - ace inhibitors, plain; lisinopril

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - lisinopril dihydrate - tablet - 5 milligram(s) - ace inhibitors, plain; lisinopril

New Zealand - English - Medsafe (Medicines Safety Authority)

bristol-myers squibb (nz) limited - abatacept 262.5mg;  ;   - powder for injection - 250 mg - active: abatacept 262.5mg     excipient: hydrochloric acid maltose monobasic sodium phosphate dihydrate sodium chloride sodium hydroxide - orencia in combination with methotrexate is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have had an insufficient response or intolerance to other disease modifying anti-rheumatic drugs (dmards), such as methotrexate or tumour necrosis factor (tnf) blocking agents. a reduction in the progression of joint damage and improvement in physical function have been demonstrated during combination treatment with orencia and methotrexate. orencia in combination with methotrexate is also indicated in the treatment of severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate. orencia is indicated for reducing signs and symptoms in paediatric patients 6 years of age and older with moderately to severely active polyarticular juvenile idiopathic arthritis who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (dmards). orencia may be used concomitantly with methotrexate (mtx). (there is no clinical trial data for the use of orencia subcutaneous formulation in children, therefore its use in children cannot be recommended.) orencia should not be administered concurrently with other biological dmards (eg, tnf inhibitors, rituximab, or anakinra).

New Zealand - English - Medsafe (Medicines Safety Authority)

bristol-myers squibb (nz) limited - abatacept 125.875mg equivalent to abatacept 125mg/ml;  ;   - solution for injection - 125 mg - active: abatacept 125.875mg equivalent to abatacept 125mg/ml     excipient: dibasic sodium phosphate monobasic sodium phosphate nitrogen poloxamer 188 sucrose water for injection - orencia in combination with methotrexate is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have had an insufficient response or intolerance to other disease modifying anti-rheumatic drugs (dmards), such as methotrexate or tumour necrosis factor (tnf) blocking agents. a reduction in the progress of joint damage and improvement in physical function have been demonstrated during combination treatment with orencia and methotrexate. orencia in combination with methotrexate is also indicated in the treatment of severe, active and progressive rheumatoid arthiritis in adults not previously treated with methotrexate. orencia should not be administered concurrently with other dmards (eg. tnf inhibitors, rituximab or anakinra).

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - ramipril - tablet - 1.25 milligram(s) - ace inhibitors, plain; ramipril